Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 15.0B | 13.6B | 14.8B | 15.0B |
Cost of revenue | 6.6B | 6.0B | 6.6B | 6.7B |
Gross profit | 8.4B | 7.6B | 8.2B | 8.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 4.6B | 4.2B | 4.6B | 4.5B |
Other operating expenses | -191M | -192M | 132M | -215M |
Operating income | 4.0B | 3.6B | 3.5B | 4.1B |
Non operating interest income | ||||
Income | — | 30M | 638M | 34M |
Expense | — | 818M | 1.4B | 904M |
Other income expense | 168M | -49M | -553M | 200M |
Pretax income | 2.4B | 3.5B | 2.5B | 3.2B |
Tax provision | — | 664M | 848M | 758M |
Net income | 1.0B | 3.5B | 1.7B | 2.5B |
Basic EPS | — | 1.1 | 0.6 | 1.0 |
Diluted EPS | — | 1.1 | 0.6 | 1.0 |
Basic average shares | — | 2.0B | 2.0B | 2.0B |
Diluted average shares | — | 2.0B | 2.0B | 2.0B |
EBITDA | 4.3B | 3.6B | 4.8B | 4.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -348M | -396M | -471M | -418M |
Preferred stock dividends | — | — | — | — |